Cargando…

The physiological basis of pulmonary arterial hypertension

Pulmonary arterial hypertension (PAH) is a rare dyspnoea-fatigue syndrome caused by a progressive increase in pulmonary vascular resistance and eventual right ventricular (RV) failure. In spite of extensive pulmonary vascular remodelling, lung function in PAH is generally well preserved, with hyperv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Naeije, Robert, Richter, Manuel J., Rubin, Lewis J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9203839/ https://www.ncbi.nlm.nih.gov/pubmed/34737219 http://dx.doi.org/10.1183/13993003.02334-2021

Ejemplares similares

The right ventricle in pulmonary arterial hypertension
por: Naeije, Robert, et al.
Publicado: (2014)

Physiology in medicine: importance of hypoxic pulmonary vasoconstriction in maintaining arterial oxygenation during acute respiratory failure
por: Naeije, Robert, et al.
Publicado: (2001)

Treprostinil for pulmonary hypertension
por: Skoro-Sajer, Nika, et al.
Publicado: (2008)

Future perspectives in pulmonary arterial hypertension
por: Simonneau, Gérald, et al.
Publicado: (2016)

Dynamic right ventricular–pulmonary arterial uncoupling during maximum incremental exercise in exercise pulmonary hypertension and pulmonary arterial hypertension
por: Singh, Inderjit, et al.
Publicado: (2019)

Pulmonary hypertension associated with COPD
por: Naeije, Robert, et al.
Publicado: (2001)

Improvement in right ventricular function during reversibility testing in pulmonary arterial hypertension: a case report
por: Huez, Sandrine, et al.
Publicado: (2009)

New horizons in pulmonary arterial hypertension management
por: McLaughlin, Vallerie, et al.
Publicado: (2014)

Right ventricular dyssynchrony: from load-independent right ventricular function to wall stress in severe pulmonary arterial hypertension
por: Richter, Manuel J., et al.
Publicado: (2020)

Reply to Weatherald et al.: Pulmonary Vascular Resistance in Pulmonary Arterial Hypertension: La Pièce de Résistance?
por: Badagliacca, Roberto, et al.
Publicado: (2021)

Overdue to understand anticoagulation in pulmonary arterial hypertension
por: Parikh, Kishan S., et al.
Publicado: (2018)

A paradigm shift in pulmonary arterial hypertension management
por: Rubin, Lewis J., et al.
Publicado: (2013)

Beta-blockade improves right ventricular diastolic function in exercising pulmonary arterial hypertension
por: Samaranayake, Chinthaka B., et al.
Publicado: (2023)

Metabolic dysfunction in pulmonary hypertension: from basic science to clinical practice
por: Chan, Stephen Y., et al.
Publicado: (2017)

Physiological basis and interpretation of indices of pulmonary mechanics.
por: Drazen, J M
Publicado: (1984)

Pulmonary arterial hypertension
por: Montani, David, et al.
Publicado: (2013)

Clinical trial design and new therapies for pulmonary arterial hypertension
por: Sitbon, Olivier, et al.
Publicado: (2019)

Against the Odds: Risk Stratification with Cardiac Magnetic Resonance Imaging in Pulmonary Arterial Hypertension
por: Richter, Manuel J., et al.
Publicado: (2020)

The Physiological Basis of Mental Activity
por: Galambos, Robert
Publicado: (1964)

Molecular Pathways in Pulmonary Arterial Hypertension
por: Shah, Aangi J., et al.
Publicado: (2022)

Relevance of Cor Pulmonale in COPD With and Without Pulmonary Hypertension: A Retrospective Cohort Study
por: Yogeswaran, Athiththan, et al.
Publicado: (2022)

Potassium Channels as Therapeutic Targets in Pulmonary Arterial Hypertension
por: Redel-Traub, Gabriel, et al.
Publicado: (2022)

Recent advances in pulmonary arterial hypertension
por: Wilkins, Martin R., et al.
Publicado: (2018)

The Glycobiology of Pulmonary Arterial Hypertension
por: Vang, Shia, et al.
Publicado: (2022)

Biomarkers in Pulmonary Arterial Hypertension
por: Hojda, Silvana Elena, et al.
Publicado: (2022)

Pregnancy in pulmonary arterial hypertension
por: Olsson, Karen M., et al.
Publicado: (2016)

Human Physiology - the Basis of Medicine
por: Allen, J Desmond
Publicado: (2008)

Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension: An Immunological Perspective
por: Koudstaal, Thomas, et al.
Publicado: (2020)

Pulmonary Arterial Hypertension and Hereditary Haemorrhagic Telangiectasia
por: Vorselaars, Veronique M. M., et al.
Publicado: (2018)

BNP/NT-proBNP in pulmonary arterial hypertension: time for point-of-care testing?
por: Lewis, Robert A., et al.
Publicado: (2020)

Selexipag in the management of pulmonary arterial hypertension: an update
por: Coghlan, J Gerry, et al.
Publicado: (2019)

Determinants of an elevated pulmonary arterial pressure in patients with pulmonary arterial hypertension
por: Sakao, Seiichiro, et al.
Publicado: (2015)

Intravenous treprostinil via an implantable pump in pediatric pulmonary arterial hypertension
por: Desole, Susanna, et al.
Publicado: (2018)

New Drugs and Therapies in Pulmonary Arterial Hypertension
por: Shah, Aangi J., et al.
Publicado: (2023)

THE PHYSIOLOGICAL BASIS OF HABITUATION
Publicado: (1966)

THE PHYSIOLOGICAL BASIS OF PHYSIOTHERAPY
Publicado: (1979)

Pulmonary arterial hypertension: an update
por: Hoendermis, E. S.
Publicado: (2011)

Advanced risk stratification of intermediate risk group in pulmonary arterial hypertension
por: Yogeswaran, Athiththan, et al.
Publicado: (2020)

Liver abnormalities in pulmonary arterial hypertension
por: Nickel, Nils P., et al.
Publicado: (2021)

Riociguat and the right ventricle in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
por: Benza, Raymond L., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_p0us0ols03mknqucgevpl7602a